Global Rapid Antimicrobial Susceptibility Testing Market Growth 2023-2029

Global Rapid Antimicrobial Susceptibility Testing Market Growth 2023-2029

The global Rapid Antimicrobial Susceptibility Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Rapid Antimicrobial Susceptibility Testing players cover BioMérieux, BD, Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, Bruker, Roche Diagnostics, Accelerate Diagnostics and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Susceptibility testing is used to determine which antimicrobials will inhibit the growth of the bacteria or fungi causing a specific infection.

LPI (LP Information)' newest research report, the “Rapid Antimicrobial Susceptibility Testing Industry Forecast” looks at past sales and reviews total world Rapid Antimicrobial Susceptibility Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Antimicrobial Susceptibility Testing sales for 2023 through 2029. With Rapid Antimicrobial Susceptibility Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Antimicrobial Susceptibility Testing industry.

This Insight Report provides a comprehensive analysis of the global Rapid Antimicrobial Susceptibility Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Antimicrobial Susceptibility Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rapid Antimicrobial Susceptibility Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Antimicrobial Susceptibility Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Antimicrobial Susceptibility Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Antimicrobial Susceptibility Testing market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Others

Segmentation by application
Clinical Diagnostics
Drug Development
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioMérieux
BD
Thermo Fisher Scientific
Danaher
Bio-Rad Laboratories
Bruker
Roche Diagnostics
Accelerate Diagnostics
Merck
HiMedia Laboratories
Liofilchem S.R.L Diagnostics
Alifax S.r.l.
Creative Diagnostics
Synbiosis
Bioanalyse
ZHUHAI DL BIOTECH
ELITechGroup
Mast Group
CONDALAB
Genefluidics
Biotron
InvivoGen
MP Biomedicals
QuantaMatrix
PML Microbiologicals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rapid Antimicrobial Susceptibility Testing market?

What factors are driving Rapid Antimicrobial Susceptibility Testing market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rapid Antimicrobial Susceptibility Testing market opportunities vary by end market size?

How does Rapid Antimicrobial Susceptibility Testing break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.